Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 2 of 9

David Pugh, a former physical chemist at AstraZeneca, now a technology analyst at the Cambridge-based company IDTechEx say patients’ desire for something more convenient is helping to push research into ‘minimally-invasive’ glucose monitoring

David Pugh, a former physical chemist at AstraZeneca Pharmaceuticals, now a technology analyst at the Cambridge-based company IDTechEx, says that patients’ desire for something more convenient is helping to push research into ‘minimally-invasive’ or truly non-invasive glucose monitoring

Source  Courtesy of David Pugh